Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 44 | $36,967,261 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Jun 2024 16:05 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 03 Jun 2024 | Sale | 50,000 | 40.6104 | 2,030,520 | D |
14 May 2024 17:16 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 10 May 2024 | Sale | 50,000 | 42.1025 | 2,105,125 | D |
03 Apr 2024 16:15 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 01 Apr 2024 | Sale | 50,000 | 42.3328 | 2,116,640 | D |
06 Mar 2024 16:15 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 04 Mar 2024 | Sale | 50,000 | 41.011 | 2,050,550 | D |
04 Mar 2024 17:49 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 29 Feb 2024 | Sale | 50,000 | 41.1578 | 2,057,890 | D |
08 Feb 2024 19:14 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 07 Feb 2024 | Sale | 2,506 | 41.5441 | 104,110 | D |
04 Jan 2024 16:15 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 02 Jan 2024 | Sale | 50,000 | 42.2363 | 2,111,815 | D |
16 Nov 2023 16:15 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 14 Nov 2023 | Sale | 22,824 | 25.1251 | 573,455 | D |
09 Nov 2023 17:03 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 08 Nov 2023 | Sale | 100 | 25.16 | 2,516 | D |
09 Nov 2023 17:03 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 07 Nov 2023 | Sale | 27,076 | 25.0242 | 677,555 | D |
06 Nov 2023 17:12 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 03 Nov 2023 | Sale | 61,401 | 25.4305 | 1,561,458 | D |
06 Nov 2023 17:12 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 02 Nov 2023 | Sale | 38,599 | 25.1882 | 972,239 | D |
08 Sep 2023 16:35 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 07 Sep 2023 | Sale | 50,000 | 24.0683 | 1,203,415 | D |
13 Jul 2023 17:41 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | Director | 11 Jul 2023 | Sale | 50,000 | 30.0268 | 1,501,340 | D |
05 Jun 2023 20:12 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 01 Jun 2023 | Sale | 50,000 | 32.6014 | 1,630,070 | D |
08 May 2023 16:24 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 04 May 2023 | Sale | 300 | 32.93 | 9,879 | D |
08 May 2023 16:24 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 04 May 2023 | Sale | 12,132 | 31.7579 | 385,287 | D |
08 May 2023 16:24 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 04 May 2023 | Sale | 37,568 | 31.3636 | 1,178,268 | D |
13 Apr 2023 16:48 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 11 Apr 2023 | Sale | 50,000 | 25.0626 | 1,253,130 | D |
06 Mar 2023 16:15 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 03 Mar 2023 | Sale | 3,000 | 27.19 | 81,570 | D |
06 Mar 2023 16:15 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 02 Mar 2023 | Sale | 47,000 | 27.1144 | 1,274,377 | D |
08 Feb 2023 20:27 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 07 Feb 2023 | Sale | 7,942 | 33.5745 | 266,649 | D |
08 Feb 2023 20:27 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 07 Feb 2023 | Sale | 42,058 | 33.0437 | 1,389,752 | D |
06 Jan 2023 17:04 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 05 Jan 2023 | Sale | 500 | 30.732 | 15,366 | D |
06 Jan 2023 17:04 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 05 Jan 2023 | Sale | 49,500 | 29.9294 | 1,481,505 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 311 | 716.08 | 222,701 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 2,266 | 715.48 | 1,621,278 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 1,022 | 714.61 | 730,331 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 1,198 | 713.66 | 854,965 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 100 | 711.95 | 71,195 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 679 | 710.63 | 482,518 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 1 | 709.92 | 710 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 181 | 707.87 | 128,124 | D |
13 Dec 2022 16:44 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 09 Dec 2022 | Sale | 5,145 | 27.0932 | 139,395 | D |
13 Dec 2022 16:44 | CERE | Cerevel Therapeutics Holdings Inc | COLES N ANTHONY | CEO and Chairperson | 09 Dec 2022 | Sale | 44,855 | 26.617 | 1,193,906 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 602 | 584.57 | 351,911 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 1,045 | 583.16 | 609,402 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 1,220 | 582.56 | 710,723 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 822 | 581.44 | 477,944 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 688 | 580.44 | 399,343 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 550 | 579.85 | 318,918 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 273 | 578.25 | 157,862 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 500 | 577.07 | 288,535 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 300 | 576.73 | 173,019 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)